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T he gestational age (GA) that constitutes the limit of viability is a persistent question for perinatal care providers. Advances in perinatal-neonatal medicine over the past 2 decades have decreased mortality and morbidity of preterm lowbirth-weight infants. [1] [2] [3] [4] [5] For example, in Sweden, the 1-year survival rate of infants born at 22 to 26 weeks of gestation between 2004 and 2007 reached 70%, ranging from 9.8% at a GA of 22 weeks to 85% at a GA of 26 weeks. 6 In 2005, the survival rates of Japanese infants during their stay in neonatal intensive care units (NICUs) were 34.0%, 54.2%, and 76.6% at 22, 23, and 24 weeks of gestation, respectively. 7 Birth weight (BW) and GA, alone or in combination, have often been used as predictors of the outcome and criteria for periviable infants. [8] [9] [10] This can be problematic because GA assessment is not always accurate, especially for mothers who may not undergo an early ultrasonographic assessment. 11 BW is an objective tool for postnatal prediction of the outcome of periviable infants but data on the outcome of infants with a BW of ≤500 g are limited. [12] [13] [14] [15] [16] [17] [18] Therefore, most of the available data for infants with a BW of ≤500 g have been extrapolated from studies carried out on preterm or low-birth-weight infants. 4, 5, [19] [20] [21] [22] [23] [24] [25] [26] An anticipated periviable birth offers challenges for the parents and perinatal care professionals. Clinicians and families must make treatment decisions on the basis of parental preferences and the available clinical data. 27 To provide data focused on periviable infant outcomes, the present study investigated the rates of neonatal mortalities and morbidities of infants with a BW of ≤500 g using the nationwide cohort database in Japan.
Methods
Patient data were obtained from the Neonatal Research Network of Japan (NRNJ) database. This database prospectively registered all of the clinical information of infants with a BW of ≤1500 g admitted to the 204 participating NICUs (see Appendix; available at www.jpeds.com). 4, 19 Data were collected by data abstractors in each NICU with use of a standard network database operation manual, and were sent on a yearly basis to the NRNJ Database Center located at the Maternal and Perinatal Center in the Tokyo Women's Medical University. A total of 1613 live-born infants with a BW of ≤500 g born between January 1, 2003, and December 31, 2012, were eligible (Figure 1 ; available at www.jpeds.com). Data on stillbirth and intrapartum death were not registered in the NRNJ. The following infants were excluded: 44 infants who were not admitted to the NICU because of death in the operating or delivery room; 71 infants with unidentified outcomes because they were transferred to other hospitals; 3 infants born at a GA of <22 weeks; and 22 infants without records of mortality status. Ultimately, 1473 infants were enrolled as the study population.
During the study period, the clinician's perspective on active treatment or withdrawal of care for preterm labor and infants at born a GA of 22 and 23 weeks and a BW of ≤500 g depended on the clinical status of the fetus or infant. After 23 weeks of gestation, clinicians attempted to save the infants regardless of BW. Antenatal corticosteroids were administered to women if delivery at 22 to 33 weeks was considered to be inevitable. Cesarean delivery was performed for presumed nonreassuring fetal status and other medical or obstetric indications, depending on the clinical status of the fetus and mother.
This study was approved by the Internal Review Board of Tokyo Women's Medical University. Written informed consent was obtained from the parents or guardians of all infants in the NRNJ.
The GA was calculated based on an ultrasound examination in early pregnancy and the date of the last menstrual period. Small for GA was defined as a BW of less than the 10th percentile for the GA. 28 Major congenital abnormalities did not include external malformations. Maternal diabetes and hypertension were diagnosed using standard criteria. 29 Chorioamnionitis was diagnosed clinically during pregnancy, labor, or delivery. Premature rupture of membranes was defined as rupture of membranes before the onset of labor. Antenatal use of corticosteroids was defined as the administration of corticosteroids to the mother at any time before delivery. Nonreassuring fetal status was diagnosed using cardiotocography. Moderate to severe bronchopulmonary dysplasia was defined as the need for supplemental oxygen or positive pressure at 36 weeks' postmenstrual age. 30 Patent ductus arteriosus was diagnosed based on both echocardiographic and clinical findings. Severe intraventricular hemorrhage was reported according to the classification of Papile et al 31 as grade III and IV. Cystic periventricular leukomalacia was defined as any cyst formation observed at any time in the periventricular white matter on cranial ultrasound or head magnetic resonance imaging. Sepsis was defined as culture-proven septicemia or bacteremia during the NICU stay. Severe necrotizing enterocolitis was diagnosed by pneumoperitoneum on a plain radiograph examination or reported according to the classification of Bell et al 32 as stage ≥2. Retinopathy of prematurity was coded if treatment was required with laser coagulation or cryocoagulation.
Statistical Analyses
Statistical analyses were performed using the software program JMP 11.0 (SAS Institute, Cary, North Carolina). Results with a P value of <.05 were considered significant. Comparisons among the cumulative survival rates classified by the BW were performed by a Kaplan-Meier analysis. A multivariable Cox proportional hazards model was used to estimate the HRs and the 95% CIs for the survival time. Variables with P < .05 in the univariate analysis were selected for inclusion in the multivariable model.
Results
A total of 1473 infants (males: 657; females: 815; unidentified: 1) were born at a median GA of 24 3/7 weeks of gestation (range, 22
) and median BW of 452 g (range, 182-500). The median observation period (from birth to death in the NICU or hospital discharge) was 135 days (range, 0-1667). Of all infants with a BW of ≤500 g, 811 (55%; 95% CI 53%-58%) survived to hospital discharge, and 662 died during the NICU stay. The survival rates differed between those with a BW of 401-500 g (n = 1162) and 301-400 g (n = 261; 60% [95% CI 57%-63%] vs 41% [95% CI 36%-47%]; P < .01). Of the 50 neonates weighing ≤300 g, only 9 (18%; 95% CI 10%-31%) survived. The 60-day overall survival rates were significantly different among the BW categories of ≤300 g, 301-400 g, and 401-500 g (each log-rank P < .01; Figure 2 , A).
Forty-four infants were born at a median GA and BW of 22 4/7 and 421 g, respectively, and were excluded from the study because of death in the operating or delivery room (Figure 1 ). When they were included in the survival analysis, 811 of 1517 infants (53%; 95% CI 51%-56%) with a BW of ≤500 g survived to hospital discharge. The survival rates for a BW of 401-500 g (n = 1188), 301-400 g (n = 271), and ≤300 g (n = 58) were 58% (95% CI 56%-61%), 40% (95% CI 34%-46%), and 16% (95% CI 8%-27%), respectively. Table I presents the perinatal characteristics of the surviving (n = 811) and nonsurviving infants (n = 662). The proportion of maternal hypertension was higher in the survivors than in the nonsurvivors (P < .01). The proportion of premature rupture of membranes in the survivors was lower than in the nonsurvivors (P = .02). Surviving infants were exposed more frequently to antenatal corticosteroids (P < .01) or delivered by cesarean delivery (P < .01) than the non surviving infants. The median GA and BW in the survivors were higher than in the nonsurvivors (P < .01). The survivors had higher proportions of small for GA (P < .01) and Apgar score ≥4 points at 5 minutes after birth (P < .01) than the nonsurvivors.
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The proportion of having major congenital abnormalities (P < .01) was lower in the survivors than in the nonsurvivors.
A multivariable Cox proportional hazards analysis (Table II) revealed that survival to discharge was associated significantly with the use of antenatal corticosteroids, cesarean delivery, advanced GA per week, BW per 100-g increase, Apgar score ≥4 points at 5 minutes after birth, and no major congenital abnormalities. Survival was correlated with year of birth (r = 0.79; P < .01). Overall survival rates significantly increased from 40% in 2003 (95% CI 30%-51%; 33 of 83 infants) to 68% in 2012 (95% CI 61%-75%; 128 of 187). When categorized by BW (≤300 g, 301-400 g, and 401-500 g; Figure 2 , B), the survival rates for infants weighing 301-400 g and 401-500 g in 2003 were 21% (95% CI 9%-43%; 4 of 19) and 48% (95% CI 36%-61%; 29 of 60) respectively, increasing in 2012 to 64% (95% CI 47%-78%; 21 of 33) and 71% (95% CI 63%-78%; 106 of 149), respectively. There was a significant increase for the 301-400 g (r = 0.84; P < .01) and 401-500 g groups (r = 0.79; P < .01) but not the ≤300 g group. The slope indices did not differ between the 301-400 g and 401-500 g groups. When the study period was divided into the first 5 years Table III ; available at www.jpeds.com), infants in the first 5 years were exposed less frequently to antenatal corticosteroids (35% vs 52%; P < .01), cesarean delivery (68% vs 74%; P = .01), and surfactant (77% vs 84%; P < .01) than those in the second 5 years.
When the major morbidities were investigated in the 811 survivors, 148 (18%) were free from sequelae at the last follow-up of a median 168 days of age (range, 77-1667). Table IV shows the morbidities in the survivors (n = 811) according to the BW groups of ≤300 g (n = 9), 301-400 g (n = 108), and 401-500 g (n = 694). The incidence of any morbidity showed a decreasing trend with increasing BW. However, there was no difference in the incidence of any morbidity or each morbidity among these 3 groups. When the study period was divided into these 2 periods, the incidence of any morbidity was higher in the second 5 years than in the first 5 years (Table V; available at www.jpeds.com). P values from a c 2 test. a; ≤300 g vs 301-400 g, b, ≤300 g vs 401-500 g; c, 301-400 g vs 401-500 g. *Total number with available information.
Discussion
In a nationwide cohort (the NRNJ), the overall survival for infants with a BW of ≤500 g born from 2003 to 2012 was 55% (95% CI 53%-58%), with survival rates increasing from 18% for infants weighing ≤300 g to 60% for infants weighing 401-500 g. A multivariable hazards analysis revealed that the survival factors were antenatal corticosteroids, cesarean delivery, advanced GA, increasing BW, higher Apgar scores, and no major congenital abnormalities. Although the survival rate has greatly improved over the 10-year study period, from 40% in 2003 to 68% in 2012, most survivors had some major morbidities that might affect their long-term prognosis.
We reviewed the English literature on the outcomes of infants born with a BW of ≤500 g by using the PubMed database (Table VI; available at www.jpeds.com). [12] [13] [14] [15] [16] [17] [18] A previous cohort study of live-born periviable fetuses (200-499 g) in the United States reported survival rates to discharge of 12.0% in 1985-1988 and 17.4% in 1995-1999. 15 Recently, a small number of population-based studies (including 17-212 infants) found that the survival rates of infants with a BW of ≤500 g ranged from 29% to 60%, 14, [16] [17] [18] all lower than the 68% survival rate reported in this study for 2012 Japanese births. However, the 2010 American Heart Association guidelines on neonatal resuscitation state that withholding resuscitative efforts may be reasonable for infants with a GA of <23 weeks or a BW of <400 g based on the margins of viability. 10 In the present study, several factors were associated independently with an increasing survival rate for infants with a BW of ≤500 g. These findings are largely consistent with those of previous studies. 9, 20, 27, 33 A US cohort study of infants with a BW of <500 g 15 reported that maternal age ≥35 years, BW ≥350 g, higher GA, and singleton birth were associated with enhanced survival rates. Antenatal corticosteroids were recommended for all women at risk for preterm birth in 1994. 34 There were no differences in risk factors such as GA, BW, Apgar score, or major congenital abnormalities in the first and second halves of our 10-year study period, but the survival and the proportions of antenatal corticosteroid therapy and caesarean delivery were higher in the second 5 years than in the first 5 years in Japan (Table III) . We speculate that the increase in obstetric interventions might have improved the short-term survival of infants with a BW of ≤500 g in the later 5-year period.
The incidence of morbidities in early infancy were similar to those obtained in a previous report from the Vermont Oxford Network Database (1996) (1997) (1998) (1999) (2000) . 13 In that report, 35% of infants with a BW of 401-500 g who were admitted to NICUs survived until discharge, and the researchers noted high rates of serious morbidities in the NICU, including bronchopulmonary dysplasia in 74%, patent ductus arteriosus ligation in 14%, severe intraventricular hemorrhage in 8%, necrotizing enterocolitis in 14%, and severe retinopathy of prematurity in 40% of the survivors 13 ( Table VI) . The long-term neurodevelopmental and pulmonary outcomes and quality of life in these tiny infants should be clarified in future studies.
Recent progress in perinatal-neonatal medicine in Japan has helped to improve the survival rate of previable infants. In the present study, more than 2 of 3 infants with a BW of ≤500 g and ≥1 of 2 infants with a BW of 301-400 g survived to hospital discharge in Japan. One in 5 infants then survived without severe complications in infancy. The high morbidity rate of survivors remains a global issue, despite encouraging survival rates (Table VI) . Although technology can help to overcome the biological limitations of premature infants, they need further support to prevent or alleviate major morbidities. To resolve the ethical and economic problems, further progress is needed, ranging from overall improved care to more sophisticated management of periviable infants using technologies such as tissue engineering and regenerative medicine.
Several limitations associated with the present study warrant mention. The first limitation is the lack of information on the decisions about the treatment or treatment restrictions for the periviable birth in the database. Therefore, survival in this report might be higher than that for all births and all live-born infants. We were unable to validate the differences in the critical care for periviable infants among the affiliated hospitals. We did not assess the detailed causes of death during the NICU stay and after hospital discharge in each subject. In addition, given the health care system in Japan, we should also consider the short-and long-term financial burden for each patient.
In conclusion, our results provide evidence that improvements in perinatal-neonatal medicine have contributed to the survival but not the improvement of major morbidities in infants with a BW of ≤500 g. This information should be taken into consideration when making decisions regarding resuscitation, counseling parents, and advising parents during their infant's NICU stay. ■ Figure 1 . Patient enrollment. This study population consisted of all infants with a BW of ≤500 g who were treated in the affiliated NICUs and met the exclusion criteria. VLBW, very low birth weight. 
